Viking Therapeutics Inc (NASDAQ:VKTX) price closed higher on current market day and jumping 5.69% above its previous close.
A look at the daily price movement shows that the last close reads $27.57. Taking into account the 52-week price action we note that the stock hit a 52-week high of $81.73 and 52-week low of $18.92. The stock added 5.77% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 7 analysts have assigned VKTX a recommendation rating as follows: 0 rate it as a Hold; 6 advise Buy while 1 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Viking Therapeutics Inc (VKTX) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that VKTX’s price is at present 6.19% off the SMA20 and 11.49% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.16, with weekly volatility standing at 2.91%. The indicator jumps to 3.25% when calculated based on the past 30 days. Viking Therapeutics Inc (NASDAQ:VKTX)’s beta value is holding at 0.64, while the average true range (ATR) indicator is currently reading 1.62. Considering analysts have assigned the stock a price target range of $75-$75 as the low and high respectively, we find the trailing 12-month average consensus price target to be $75. Based on this estimate, we see that current price is roughly -157.38% off the estimated low and -157.38% off the forecast high. Investors will no doubt be excited to see the share price fall to $75, which is the median consensus price, and at that level VKTX would be -157.38% from current price.
Current records show that the company has 112.29M in outstanding shares. The insiders’ percentage holdings are 2.96% of outstanding shares while the percentage share held by institutions stands at 69.46%. But the -27.58% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
